Clinical Trials
5 trialsNCT06087419 2023-11-02
A Prospective Clinical Study of Bridging alloHSCT After Treatment With Obinutuzumab in Combination With Chidamide and Venetoclax in RR Ph-ALL and B-cell Lymphoma Patients
Institute of Hematology & Blood Diseases Hospital, China
Phase 1/2 Unknown
NCT03249870 2023-09-06
EWALL-INO
Versailles Hospital
Phase 2 Unknown
NCT03460522 2022-11-02
Inotuzumab Ozogamicin and Conventional Chemotherapy In Patients Aged 56 Years and Older With ALL
Goethe University
Phase 2 Unknown
NCT05603156 2022-11-02
A Study of Olverembatinib Combined With Inotuzumab Ozogamicin in the Treatment ph+ ALL With MRD Persistent Positive
Institute of Hematology & Blood Diseases Hospital, China
Phase NA Unknown
NCT03610438 2022-01-04
ALL2418
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase 2 Unknown